Overall, there was a high proportion of patients reaching clinical stability in the macrolide group compared with the monotherapy group, which did not reach statistical significance (41.2% versus 33.6%; p=0.07).
1
0.0700
0.0700
Overall, there was a high proportion of patients reaching clinical stability in the macrolide group compared with the monotherapy group, which did not reach statistical significance (41.2% versus 33.6%; p=0.07).